Site specific monoclonal antibodies to insulin

Large Lung Volumes Delay the Onset of the Physiological Breaking Point During Simulated Diving.

Frontiers in physiology·2021

c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells.

Leukemia·2011

The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells.

Oncogene·2006

Frequent inactivation of the cyclin-dependent kinase inhibitor p18 by homozygous deletion in multiple myeloma cell lines: ectopic p18 expression inhibits growth and induces apoptosis.

Leukemia·2002

A novel system to identify Myb target promoters in friend murine erythroleukemia cells.

Blood cells, molecules & diseases·2001

c-myb transactivates the human cyclin A1 promoter and induces cyclin A1 gene expression.

Blood·1999

Clinical Europium fluorescent based lectin assays for mucin O-glycomics.

Methods in enzymology·2026

A dual-color FRET assay for detection and quantitative analysis of O-glycopeptidases.

Methods in enzymology·2026

Evolutionary genetic approaches to analyze mucins.

Methods in enzymology·2026

Ex vivo imaging and enzymatic analysis of intestinal mucus.

Methods in enzymology·2026

Glyco-TRAPP: A real-time glycocalyx permeability assay for assessing transmembrane mucin barrier function in live and fixed tissues.

Methods in enzymology·2026

Quantitative imaging approaches to capture structural and functional dynamics of colonic mucus in health and disease in situ.

Methods in enzymology·2026

Blinatumomab administration in the outpatient setting: Safety and health care utilization.

Cancer·2026

Subcutaneous versus intravenous ultra-low dose rituximab in rheumatoid arthritis: a randomised controlled PK-PD non-inferiority trial.

Rheumatology (Oxford, England)·2026

The Role of γδ T Cells in Ischemic Stroke: Insights From the Perspective of the Brain-Gut Axis.

CNS neuroscience & therapeutics·2026

Macrophage migration inhibitory factor promotes immune evasion in multiple myeloma through myeloid-derived suppressor cell immunosuppression and major histocompatibility complex class I downregulation: implications for targeted therapy.

Haematologica·2026

Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications.

Haematologica·2026

Brentuximab vedotin as consolidation treatment in patients with stage I/II Hodgkin's lymphoma and FDG-PET positivity after 2 cycles of ABVD: final analysis of the BRAPP2 trial.

Haematologica·2026

Related Experiment Videos

Site specific monoclonal antibodies to insulin

Related Concept Videos

Large Lung Volumes Delay the Onset of the Physiological Breaking Point During Simulated Diving.

c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells.

The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells.

Frequent inactivation of the cyclin-dependent kinase inhibitor p18 by homozygous deletion in multiple myeloma cell lines: ectopic p18 expression inhibits growth and induces apoptosis.

A novel system to identify Myb target promoters in friend murine erythroleukemia cells.

c-myb transactivates the human cyclin A1 promoter and induces cyclin A1 gene expression.

Clinical Europium fluorescent based lectin assays for mucin O-glycomics.

A dual-color FRET assay for detection and quantitative analysis of O-glycopeptidases.

Evolutionary genetic approaches to analyze mucins.

Ex vivo imaging and enzymatic analysis of intestinal mucus.

Glyco-TRAPP: A real-time glycocalyx permeability assay for assessing transmembrane mucin barrier function in live and fixed tissues.

Quantitative imaging approaches to capture structural and functional dynamics of colonic mucus in health and disease in situ.

Blinatumomab administration in the outpatient setting: Safety and health care utilization.

Subcutaneous versus intravenous ultra-low dose rituximab in rheumatoid arthritis: a randomised controlled PK-PD non-inferiority trial.

The Role of γδ T Cells in Ischemic Stroke: Insights From the Perspective of the Brain-Gut Axis.

Macrophage migration inhibitory factor promotes immune evasion in multiple myeloma through myeloid-derived suppressor cell immunosuppression and major histocompatibility complex class I downregulation: implications for targeted therapy.

Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications.

Brentuximab vedotin as consolidation treatment in patients with stage I/II Hodgkin's lymphoma and FDG-PET positivity after 2 cycles of ABVD: final analysis of the BRAPP2 trial.

Related Experiment Videos

Site specific monoclonal antibodies to insulin

Related Concept Videos

Related Articles